Østergaard Jesper, Larsen Claus
Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen O, Denmark.
Molecules. 2007 Oct 30;12(10):2396-412. doi: 10.3390/12102396.
A series of model phenol carbonate ester prodrugs encompassing derivatives with fatty acid-like structures were synthesized and their stability as a function of pH (range 0.4 - 12.5) at 37 degrees C in aqueous buffer solutions investigated. The hydrolysis rates in aqueous solutions differed widely, depending on the selected pro-moieties (alkyl and aryl substituents). The observed reactivity differences could be rationalized by the inductive and steric properties of the substituent groups when taking into account that the mechanism of hydrolysis may change when the type of pro-moiety is altered, e.g. n-alkyl vs. t-butyl. Hydrolysis of the phenolic carbonate ester 2-(phenoxycarbonyloxy)-acetic acid was increased due to intramolecular catalysis, as compared to the derivatives synthesized from omega-hydroxy carboxylic acids with longer alkyl chains. The carbonate esters appear to be less reactive towards specific acid and base catalyzed hydrolysis than phenyl acetate. The results underline that it is unrealistic to expect that phenolic carbonate ester prodrugs can be utilized in ready to use aqueous formulations. The stability of the carbonate ester derivatives with fatty acid-like structures, expected to interact with the plasma protein human serum albumin, proved sufficient for further in vitro and in vivo evaluation of the potential of utilizing HSA binding in combination with the prodrug approach for optimization of drug pharmacokinetics.
合成了一系列包含具有脂肪酸样结构衍生物的模型酚碳酸酯前药,并研究了它们在37℃下于水性缓冲溶液中随pH值(范围为0.4 - 12.5)变化的稳定性。水溶液中的水解速率差异很大,这取决于所选的前体部分(烷基和芳基取代基)。考虑到当前体部分类型改变时(例如正烷基对叔丁基)水解机制可能会发生变化,观察到的反应性差异可以通过取代基的诱导和空间性质来解释。与由具有较长烷基链的ω-羟基羧酸合成的衍生物相比,酚碳酸酯2-(苯氧基羰氧基)-乙酸的水解由于分子内催化而加快。碳酸酯对特定酸和碱催化水解的反应性似乎比乙酸苯酯低。结果强调,期望酚碳酸酯前药可用于即用型水性制剂是不现实的。具有脂肪酸样结构的碳酸酯衍生物的稳定性有望与血浆蛋白人血清白蛋白相互作用,事实证明其稳定性足以用于进一步体外和体内评估利用HSA结合与前药方法相结合优化药物药代动力学的潜力。